exemestane
IBCSG 25-02 / BIG 3-02
Phase 3 small_molecule completed
Quick answer
exemestane for Breast Cancer is a Phase 3 program (small_molecule) at Partner Therapeutics Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Partner Therapeutics Limited
- Indication
- Breast Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed